Denali Capital Acquisition Corp. is a special purpose acquisition company (SPAC) that focuses on identifying and merging with private companies, thereby facilitating their transition to public status
The firm targets innovative firms across various sectors with significant growth potential, aiming to create value for its shareholders and contribute to the strategic evolution of the companies it partners with. By leveraging its expertise and resources, Denali Capital Acquisition Corp. seeks to identify compelling investment opportunities and foster successful outcomes in the public market.
Alliance Global Partners has initiated coverage on Scilex Holding Company. The company explores strategic options for its subsidiary, Scilex Pharma, including potential spinoffs and dividend distributions, while anticipating significant sales from its pain treatment candidate, SEMDEXA.
Semnur Pharmaceuticals, a subsidiary of Scilex, plans a business combination with Denali Capital Acquisition Corp. Semnur's lead product, SP-102 (SEMDEXA), a novel non-opioid pain therapy for sciatica, has shown promising Phase 3 trial results.
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I Acquisition Corp.
